首页> 外文OA文献 >The use of directed evolution towards altering the substrate specificity of acyl-coenzyme A : isopenicillin N acyl transferase and transforming it from generalist to specialist
【2h】

The use of directed evolution towards altering the substrate specificity of acyl-coenzyme A : isopenicillin N acyl transferase and transforming it from generalist to specialist

机译:使用定向进化改变酰基辅酶a的底物特异性:异青霉素N酰基转移酶并将其从通才转化为专家

摘要

Acyl Coenzyme A: Isopenicillin N Acyl Transferase (AT) is a key enzyme in the biosynthesis of β-lactam antibiotics in penicillin producing organisms such as P. chrysogenum and A. nidulans. Its natural activity is to exchange the side chain of the low activity antibiotic IPN [18] for the phenylacetyl side chain resulting in the more active antibiotic Penicillin G [5]. The biosynthesis of β-lactams has been exploited towards producing these compounds for therapeutic use. However, increasing bacterial resistance means new analogues in this compound class are constantly sought.As well as improving current production methods of β-lactam antibiotics, AT's broad substrate specificity means it could potentially play a role in the development and production of alternative β-lactam antibiotics that are able to overcome resistance.This thesis describes the identification of an AT mutant with improved acylation activity (AAT activity) via screening of an AT library using a previously developed screening method. Approaches towards the development of a method for the identification of AT mutants with improved hydrolysis activity were also explored. The main problem to overcome in developing such a screen is the inhibitory effect of 6-APA [1], the product of hydrolysis, on AT's IAT activity. The first approach investigated the potential of increasing the sensitivity of an assay by targeting AT to the periplasm. A second approach using β-lactamases to hydrolyse 6-APA [1] thus freeing up the active site of AT was also investigated.
机译:酰基辅酶A:异青霉素N酰基转移酶(AT)是在产青霉素的生物(如产黄青霉和构巢曲霉)中β-内酰胺抗生素生物合成中的关键酶。它的自然活性是将低活性抗生素IPN的侧链交换为苯乙酰基侧链,从而产生更具活性的抗生素青霉素G [5]。 β-内酰胺的生物合成已被用于生产这些用于治疗的化合物。然而,增加细菌的耐药性意味着不断寻求此类化合物中的新类似物。除了改善现有的β-内酰胺抗生素的生产方法外,AT广泛的底物特异性意味着它可能在替代β-内酰胺的开发和生产中发挥作用能够克服耐药性的抗生素。本论文描述了通过使用先前开发的筛选方法筛选AT文库来鉴定具有改善的酰化活性(AAT活性)的AT突变体。还探索了开发具有提高的水解活性的AT突变体的鉴定方法的方法。开发此类筛选所要克服的主要问题是水解产物6-APA [1]对AT的IAT活性的抑制作用。第一种方法研究了通过将AT靶向周质来提高测定灵敏度的潜力。还研究了使用β-内酰胺酶水解6-APA从而释放AT活性位点的第二种方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号